-
Symbol
-
CADL on Nasdaq
-
Investment type
-
Equity / Common stock, par value $0.0001 per share
-
Latest Disclosed Ownership
-
0 shares
-
Security Ownership
-
0%
Northpond Ventures, LP ownership in Candel Therapeutics, Inc. Common stock, par value $0.0001 per share (CADL)
2025-02-14 - Northpond Ventures, LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 0 shares of Candel Therapeutics, Inc. Common stock, par value $0.0001 per share (CADL).
This represents 0% percent ownership of the company.